Skin equivalent and natural killer cells: A new model for psoriasis and GVHD

Journal of Investigative Dermatology

Volumn 129, Issue 3, 2009, Pages 773-776

  Kalish, Richard S ^a   Simon, Marcia ^a   Harrington, Robin ^a   Gottlieb, Alice B ^b   Gilhar, Amos ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ACTIVITY; CELL ISOLATION; DISEASE MODEL; EPIDERMIS; FIBROBLAST; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL CULTURE; KERATINOCYTE; LETTER; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; SKIN GRAFT; TECHNIQUE;

EID: 59949096905     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.285     Document Type: Letter

References (12)

1. Boehncke WH (2001) Biologic effects of bacterial superantigens in a xenogeneic transplantation model for psoriasis. J Investig Dermatol Symp Proc 6:231-2
2. Boehncke WH, Kock M, Hardt-Weinelt K, Wolter M, Kaufmann R (1999) The SCID-hu xenogeneic transplantation model allows screening of anti-psoriatic drugs. Arch Dermatol Res 291:104-6
3. Dam TN, Kang S, Nickoloff BJ, Voorhees JJ (1999) 1alpha,25- dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted onto SCID mice. J Invest Dermatol 113:1082-9
4. Gilhar A, Ullmann Y, Kerner H, Assy B, Shalaginov R, Serafimovich S et al. (2002) Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with NK receptors. J Invest Dermatol 119:384-91
5. Gilhar A, Yaniv R, Assy B, Serafimovich S, Ullmann Y, Kalish RS (2006) Fas pulls the trigger on psoriasis. Am J Pathol 168:170-5
6. Gudjonsson JE, Johnston A, Dyson M, Valdimarsson H, Elder JT (2007) Mouse model of psoriasis. J Invest Dermatol 127:1292-308
7. Moulton KS, Melder RJ, Dharnidharka VR, Hardin-Young J, Jain RK, Briscoe DM (1999) Angiogenesis in the huPBL-SCID model of human transplant rejection. Transplantation 67:1626-31
8. Nickoloff BJ (2000a) Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis. J Investig Dermatol Symp Proc 5:67-73
9. Nickoloff BJ, Bonish B, Huang BB, Porcelli SA (2000b) Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci 24:212-25
10. Wang CK, Nelson CF, Brinkman AM, Miller AC, Hoeffler WK (2000) Spontaneous cell sorting of fibroblasts and keratinocytes creates an organotypic human skin equivalent. J Invest Dermatol 114:674-80
11. Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98:1878-87
12. Zeigler M, Chi Y, Tumas DB, Bodary S, Tang H, Varani J (2001) Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with cyclosporin A and clobetasol propionate. Lab Invest 81:1253-61